Test Price
2,800 AED✅ Home Collection Available
DYSF Gene Myopathy, Distal with Anterior Tibial Onset Genetic Test in UAE | 2800 AED | DHA Certified
Executive Summary & Core Metrics
Executive Summary
Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO‑accredited NGS processing, delivering clinically actionable results for distal myopathy and related dysferlinopathies.
Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM across all Emirates.
Clinical Guidance: Telephonic post‑test clinical guidance to assist in result interpretation and next‑step care planning.
Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731 (pre‑authorisation supported).
Test Overview & Methodology
The DYSF NGS test identifies pathogenic variants in the dysferlin gene, enabling accurate molecular diagnosis of distal myopathy with anterior tibial onset (Miyoshi myopathy) and related LGMD2B. This test sequences the entire coding region and flanking splice junctions using Next‑Generation Sequencing, providing a definitive genetic diagnosis for symptomatic individuals or at‑risk family members.
| Feature | Our Test | Closest Alternative |
|---|---|---|
| Precision | 99.9% – full gene coverage with copy number analysis | Sanger sequencing; may miss deep intronic variants |
| Method | NGS (Next‑Generation Sequencing) | Sanger sequencing of selected exons |
| Turnaround | 3 – 4 weeks | 6 – 8 weeks |
Physician Insight & Safety Protocols
“The dysferlin gene test is an important tool for confirming a diagnosis of distal myopathy or LGMD2B. However, results must always be interpreted alongside clinical findings and family history. A negative result does not exclude all neuromuscular disorders; comprehensive neurological assessment remains essential.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Important Precautions
Medication Warning
⚠️ Do not discontinue any prescribed medication without consulting your treating physician. Genetic test results should not be used as the sole basis for altering your treatment regimen.
Safety & Exclusion Criteria
- Exclusion Criteria: Asymptomatic minors without court‑appointed guardian consent as per Federal Decree-Law No. 4 of 2016 on Medical Liability and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Not intended for forensic or non‑clinical research use.
- ER Red Flags: If the patient experiences sudden muscle weakness causing falls, respiratory difficulty, or new‑onset cardiac symptoms, seek emergency care immediately and inform the attending physician about the suspected dysferlinopathy.
- Pre‑test Requirement: A formal genetic counselling session to draw a detailed pedigree chart of affected family members is mandatory before sample collection.
Patient FAQ & Clinical Guidance
1. What exactly does the DYSF gene test detect?
This test identifies disease‑causing variants in the DYSF gene responsible for distal myopathy and related limb‑girdle muscular dystrophy. It sequences the entire coding region and flanking splice junctions using NGS, providing a definitive genetic diagnosis for symptomatic individuals or at‑risk family members. The report details pathogenic, likely pathogenic, and variants of uncertain significance according to ACMG 2026 guidelines.
2. How long does it take to receive the results in the UAE?
Results are typically delivered within 3 to 4 weeks from the date the sample arrives at our laboratory. This includes DNA extraction, NGS sequencing, bioinformatics analysis, and a comprehensive interpretation by our clinical genomics team. You will receive a secure electronic report, and our telephonic guidance service can be scheduled within 72 hours of report availability.
3. Can I get a home blood collection for this genetic test?
Yes, we offer VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM across all Emirates. Our DHA‑licensed phlebotomists arrive with full personal protective equipment and the appropriate FTA card or EDTA tubes. Simply schedule via WhatsApp at +971 54 548 8731; we will verify your location and insurance eligibility before dispatch. All specimens are handled in compliance with UAE PDPL data privacy regulations.
UAE Regulatory & Data Privacy Adherence
Compliance Framework
This test and all related services comply with:
• Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL)
• Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields
• Federal Decree-Law No. 4 of 2016 on Medical Liability
Our facility is licensed by the Dubai Health Authority (DHA Facility License No. 1143). Clinical interpretation is supervised by Lina Osama Zaki Quteineh (DHA Registration ID: 9294403). All data handling follows ISO 27001 standards for information security.
Clinical & Logistical Metadata
| Test Name | DYSF Gene Myopathy, Distal with Anterior Tibial Onset Genetic Test |
| Price (AED) | 2800 |
| Turnaround Time | 3–4 weeks |
| Sample Type / Matrix | Peripheral Blood (EDTA or FTA card) |
| Methodology Used | Next-Generation Sequencing (NGS) with full gene coverage and copy number analysis |
| ICD-10-CM Code | G71.0 |
| LOINC Code | 81263-6 |
| DHA Facility License & Laboratory Address | DHA Facility License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians